Evidence 1
Activity
Activity
0.026% Hemolysis
Toxicity
256 µg/mL
Hemolytic
Cytotoxic
0.026% Hemolysis | 256 | µg/mL | target cell: Mouse erythrocytes
Target
Mouse erythrocytes
Source & Reference
NA
DBAASP
Development of chimeric peptides to facilitate the neutralisation of lipopolysaccharides during bactericidal targeting of multidrug-resistant Escherichia coli. | Commun Biol | 2020